The first stop for professional medicines advice

Cabergoline

Published
Topics: CabergolineMental health and illnessNeurological disorders · Obstetrics and gynaecologySafety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Articles
  3. Medicine Compliance Aid Stability
    1. Cabaser · Pfizerr Ltd
  4. Lactation Safety Information
    1. For Parkinson's disease
    2. For hyperprolactinaemic disorders
    3. For lactation suppression

dm+d

109139002

Articles

Parkinson’s disease medicines in swallowing difficulties

13 June 2022Guidance to help you ensure your patients with Parkinson’s Disease are able to get the most from their medicines if they develop swallowing difficulties
Search Articles

Medicine Compliance Aid Stability

CabaserPfizerr Ltd

Pfizerr Ltd
Cabaser
Tablets 1mg, 2mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Packaging contains dessicant. Unsuitable.
22 December 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

For Parkinson's disease

For Parkinson's disease
No
Levodopa, (as co-beneldopa or co-careldopa)
May interfere with lactation
Dopamine receptor agonist
No published evidence of safety for Parkinson’s disease
Safety in Lactation: Dopaminergic drugs used in Parkinsons disease
18 September 2020
LactMed

For hyperprolactinaemic disorders

For hyperprolactinaemic disorders
No
Suppresses lactation
No published evidence of safety for hyperprolactinaemic disorders
Safety in Lactation: Bromocriptine and other dopaminergic drugs
18 September 2020
LactMed

For lactation suppression

For lactation suppression
Caution
No published evidence of safety in breastfed infants
Suppresses lactation, although low doses may be used to reduce, and not completely stop, milk production, in which case monitor infant for cabergoline-associated side effects (hypotension, constipation, drowsiness)
Safety in Lactation: Bromocriptine and other dopaminergic drugs
18 September 2020
LactMed